Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

Bayer Acquires Herbal Medicine Maker Steigerwald

By BiotechDaily International staff writers
Posted on 27 May 2013
Pharmaceutical giant Bayer AG (Leverkusen, Germany) has agreed to buy privately held Steigerwald Arzneimittelwerk (Darmstadt, Germany), a maker of herbal treatments.

The acquisition is seen as a strategic move by Bayer to strengthen its consumer care business. Steigerwald’s product portfolio includes Iberogast for the treatment of functional gastrointestinal disorders and Laif for the treatment of mild to moderate depression, among others. Financial details of the transaction were not disclosed, but Bayer has made known that Steigerwald had generated sales of 61.3 million Euros in 2012. The transaction is subject to fulfillment of the usual conditions, including antitrust clearance, and is expected to close at the beginning of July 2013.

“This transaction is further evidence of our commitment to augment organic growth with strategic bolt-on acquisitions. It will allow us to provide consumers with an even broader range of self-care options,” said Marijn Dekkers, CEO of Bayer AG. “This acquisition broadens our product offering for the treatment of gastrointestinal disorders and gives us the opportunity to enhance our presence in Germany, the fast-growing regions of East-Central Europe, and the CIS countries.”

“As a family-owned business, we take great pride in what we have achieved in nurturing and developing our brands,” said Klaus Möller, one of Steigerwald’s shareholders. “We believe that Bayer, with its extensive marketing, sales, distribution, and research expertise, is well positioned to take our success to the next level.”

Iberogast is a proprietary liquid blend of nine herbs, including bitter candytuft, angelica root, milk thistle fruit, celandine herb, caraway fruit, liquorice root, peppermint herb, balm leaf, and chamomile flower. It is named after the genus (Iberis) of one of its ingredients, it is also claimed to possess anti-inflammatory, antioxidative, and free radical-inhibiting properties as well as reducing gastric acid secretion.

Laif is based on St John's wort, widely known as an herbal treatment for depression, probably due to its inhibition of reuptake of neurotransmitters such as serotonin (5 HT), similar to conventional selective serotonin reuptake inhibitor (SSRI) antidepressant drugs. The major active antidepressive constituents in St John's wort are thought to be hyperforin and hypericin, although other biologically active constituents present, for example, flavonoids and tannins, may also be involved.

Related Links:

Bayer AG
Steigerwald Arzneimittelwerk



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.